SARS-CoV-2 Omicron symptoms and adverse effects of GLP-1 RA therapy

Acta Diabetol. 2022 Oct;59(10):1383-1384. doi: 10.1007/s00592-022-01908-w. Epub 2022 Jun 3.
No abstract available

MeSH terms

  • COVID-19*
  • Drug-Related Side Effects and Adverse Reactions*
  • Glucagon-Like Peptide 1
  • Humans
  • SARS-CoV-2
  • Transcription Factors

Substances

  • Transcription Factors
  • Glucagon-Like Peptide 1